Skip to main content

From Flies to Families

From Flies to Families: How a Gene Variant May Shield Against Seizures


Researchers identified a genetic modifier of PIGA-CDG, a rare disorder that results in seizures, in a family carrying the genetic mutation and in a fruit fly model.

Gregor Mendel’s studies of inheritance patterns in pea plants helped shape researchers’ understanding of single-gene diseases, which can run in families. Some of the diseases that follow a Mendelian pattern include cystic fibrosis, color blindness, and rare seizure disorders such as phosphatidylinositol glycan class A congenital disorder of glycosylation (PIGA-CDG).

Clement Chow, a geneticist at the University of Utah Health, and his team study the role of genetic variants on disease outcomes, especially in rare diseases. Chow focused on PIGA-CDG when he and his team noticed a family carrying the PIGA mutation where some members remained unaffected by the disease. This finding led them to search for a genetic modifier that might contribute to this observation.

The researchers identified the contactin-2 (CNTN2) gene, which appeared in healthy family members with PIGA mutations. Their findings, published in The American Journal of Human Genetics, revealed that CNTN2 may be a protective genetic modifier in this disease.1 Identifying rare disease modifier genes in families could also aid in developing therapeutic targets.

While PIGA-CDG is caused by a mutation in the PIGA gene on the X chromosome, its expression varies and manifests in different symptoms. There are fewer than 100 reported individuals with the disorder, underscoring a need to better understand PIGA-CDG.

In the studied family, two brothers with PIGA-CDG developed early-onset epilepsy and mild developmental delay. Genetic testing revealed they both inherited the same PIGA variant.2 Notably, their maternal grandfather and a great-uncle also carried the variant but remained asymptomatic. Chow hypothesized that genetic modifiers might play a role in this discrepancy.

Using whole-genome sequencing and pedigree analysis of the family members, the researchers identified candidate modifier genes based on inheritance pattern: protective in healthy genetic carriers and susceptibility in those with PIGA-CDG. The team identified roughly 30 variants for each and then made a shortlist based on the predicted function of the genes involved in glycosylphosphatidylinositol (GPI) anchors.

PIGA encodes for a protein necessary for making GPI anchors, which are essential in attaching proteins to the cell membrane. Without GPI-anchored proteins, cell adhesion, signal transduction, and protection from immune destruction are affected. Based on this criterion, the researchers narrowed their list to three candidate genes.

Using a Drosophila melanogaster eye model, the team tested how the candidate genes influenced PIGA loss in vivo. Since PIGA knockdown significantly reduces eye size, researchers used this trait to assess gene interactions. The predicted protective modifiers were expected to rescue (make the eye bigger), while susceptibility candidates were expected to enhance (make the eye smaller) the PIGA phenotype. Notably, CNTN2, a GPI-anchored protein involved in neuron-glial cell interaction, was a strong protective genetic modifier, rescuing an eye size defect in the flies caused by the loss of PIGA.

The researchers also tested the motor effects of PIGA neuronal knockdown flies–known to have seizures and difficulty moving—such as climbing to the top of a vial. Flies with reduced function for both PIGA and Cont, the fruit fly ortholog to CNTN2, appeared to move more readily and showed reduced severity of seizures.

Based on these findings, the researchers believe that changes to CNTN2 are likely to protect people against the disease. With further investigations between affected families, this finding could eventually lead to a better grasp of understudied rare disorders and the development of therapies for PIGA-CDG.

“If we can use this strategy more broadly, I think we can help address the problem of phenotypic variation in rare disease,” Chow said in a press release. “I am hoping that this will be used as a roadmap moving forward.”

gene variant, seizures, epilepsy, neurological disorders, genetic mutation, ion channels, brain function, neuroprotection, synaptic transmission, hereditary traits, nervous system, neuronal excitability, seizure resistance, epilepsy research, genetic influence, neurogenetics, fruit flies, model organisms, familial epilepsy, brain signaling

#GeneVariant #Seizures #Epilepsy #NeurologicalDisorders #GeneticMutation #IonChannels #BrainFunction #Neuroprotection #SynapticTransmission #HereditaryTraits #NervousSystem #NeuronalExcitability #SeizureResistance #EpilepsyResearch #GeneticInfluence #Neurogenetics #FruitFlies #ModelOrganisms #FamilialEpilepsy #BrainSignaling

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more